Acorda Therapeutics, Inc. Gains 44.34%

Wed, Jan 13, 2021 at 05:30 PM
Acorda Therapeutics, Inc. Gains 44.34%

Acorda Therapeutics, Inc. (ACOR:NASDAQ) shot up at $6.12, representing a gain of 44.3%. On Tue 12 Jan 21, ACOR:NASDAQ touched a New 2-Week Intraday High of $4.27. The stock got featured on our News Catalysts scanner on Wed 13 Jan 21 at 10:45 AM in the 'BIOTECH' category. From Tue 29 Dec 20, the stock recorded 44.44% Up Days and 60.00% Green Days

The stock spiked on Thu 31 Dec 20 at $4.92 with a volume of 2M+, and its share price has been moving sideways in recent weeks.

About Acorda Therapeutics, Inc. (ACOR:NASDAQ)

Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.